Condition
Neuroendocrine Neoplasm clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Neuroendocrine Neoplasm clinical trials that are recruiting, at sites in 11 countries (most in United States (3), China (2), Italy (2)). By phase: Phase 2 (3), Phase 1 (1), Phase 3 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 11Countries
Newest Neuroendocrine Neoplasm clinical trials
All recruiting trials (10)
-
Somatostatin analogues after PRRT for nonfunctional neuroendocrine tumors
This study tests whether continuing somatostatin analogues after PRRT helps patients with nonfunctional neuroendocrine tumors compared with just observation.
-
CTX-471 for NCAM-positive metastatic neuroendocrine tumors
A phase 2 trial is testing CTX-471 in adults with NCAM (CD56) positive metastatic neuroendocrine tumors that have progressed after standard therapy.
-
Investigating the impact of somatostatin analogues on tumor dose during radionuclide therapy
This study is testing if stopping or continuing long-acting somatostatin treatment affects how well radionuclide therapy works for adults with neuroendocrine tumors.
-
Assessing the safety and efficacy of a new treatment for neuroendocrine tumors
This study is testing a new treatment for patients with advanced neuroendocrine tumors to see if it is safe and effective.
-
Understanding genetic causes of neuroendocrine tumors in Mexican patients
This study is trying to find out the genetic changes that cause neuroendocrine tumors in Mexican patients to help develop better treatments.
-
Young adults with gastrointestinal and neuroendocrine cancers
This study is trying to gather samples from young adults with gastrointestinal and neuroendocrine cancers to learn more about their specific needs and improve treatment options for them.
-
Combination therapy for advanced high-grade neuroendocrine neoplasms
This study is testing a new combination of three treatments to see if they can help people with advanced high-grade neuroendocrine tumors who haven't had success with standard therapies.
-
Comparing dosimetry-based and standard dose treatments for neuroendocrine neoplasms
This study is testing if giving personalized doses of a treatment for neuroendocrine tumors based on kidney function works better than the standard dose.
-
Exploring new biomarkers for diagnosing and treating neuroendocrine tumors
This study is testing new ways to diagnose and treat neuroendocrine tumors by looking at blood samples to see if they can provide better information about the cancer.
-
Gathering health information for younger cancer patients
This study is gathering health information from younger cancer patients to help improve treatments and support future research.
Related topics
Quick answers
How many Neuroendocrine Neoplasm clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in United States (3 trials), China (2 trials), Italy (2 trials), Denmark (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 1, Phase 3: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.